Larisa Rudenko

Director/Board Member at BioDiem Ltd.

81 year

Health Technology

Commercial Services

Profile

Larisa G.
Rudenko currently works at BioDiem Ltd., as Non-Independent Non-Executive Director from 2011 and Institute of Experimental Medicine, as Head-Virology Department.

Larisa Rudenko active positions

Companies	Position	Start
BioDiem Ltd. BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia.	Director/Board Member	2009-10-21
Institute of Experimental Medicine Institute of Experimental Medicine Miscellaneous Commercial ServicesCommercial Services The Institute of Experimental Medicine operates as a scientific research laboratory.	Corporate Officer/Principal	2011-02-27

All active positions of Larisa Rudenko

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Larisa Rudenko's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
BioDiem Ltd. BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia.	Health Technology
Institute of Experimental Medicine Institute of Experimental Medicine Miscellaneous Commercial ServicesCommercial Services The Institute of Experimental Medicine operates as a scientific research laboratory.	Commercial Services